凯普生物 - Financials

凯普生物 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012
+Revenue	816.0M	1.1B	5.6B	2.7B	1.4B	729.0M	580.0M	479.0M	398.0M	345.0M	264.0M	183.0M	139.0M
Revenue Growth %	-26.1%	-80.3%	109.4%	97.4%	85.7%	25.7%	21.1%	20.4%	15.4%	30.7%	44.3%	31.7%	--
Total Revenue	816.0M	1.1B	5.6B	2.7B	1.4B	729.0M	580.0M	479.0M	398.0M	345.0M	264.0M	183.0M	139.0M
Cost Of Revenue	427.0M	430.0M	1.7B	865.0M	361.0M	142.0M	95.8M	78.6M	57.1M	41.8M	36.2M	32.6M	31.7M
+Gross Profit	389.0M	674.0M	3.9B	1.8B	993.0M	587.0M	484.2M	400.4M	340.9M	303.2M	227.8M	150.4M	107.3M
Gross Margin %	47.7%	61.1%	69.4%	67.6%	73.3%	80.5%	83.5%	83.6%	85.7%	87.9%	86.3%	82.2%	77.2%
Total Operating Cost	1.7B	1.1B	3.4B	1.6B	903.0M	591.0M	473.0M	382.0M	318.0M	273.0M	192.0M	150.0M	118.0M
Selling Expenses	261.0M	279.0M	460.0M	383.0M	313.0M	260.0M	218.0M	183.0M	160.0M	143.0M	101.0M	68.4M	48.2M
Admin Expenses	221.0M	253.0M	387.0M	199.0M	133.0M	121.0M	104.0M	80.6M	94.0M	83.6M	50.9M	44.2M	37.0M
Rd Expenses	85.6M	136.0M	247.0M	115.0M	71.6M	57.4M	46.0M	33.6M	--	--	--	--	--
Finance Expenses	983,600	-11.5M	-2.8M	3.8M	-2.8M	453,700	217,200	-1.6M	846,800	519,500	114,800	1.2M	-560,800
+Operating Income	-822.0M	42.6M	2.2B	1.1B	469.0M	156.0M	126.0M	110.0M	80.4M	72.0M	72.1M	33.1M	21.3M
Operating Margin %	-100.7%	3.9%	39.2%	40.2%	34.6%	21.4%	21.7%	23.0%	20.2%	20.9%	27.3%	18.1%	15.3%
Non Operating Income	731,900	587,600	264,200	2.6M	7,800	854,000	1.4M	838,600	4.8M	3.8M	831,800	366,400	1.1M
Non Operating Expenses	12.0M	6.4M	65.6M	19.2M	4.9M	2.6M	1.5M	1.4M	328,600	1.6M	139,000	388,400	48,500
Investment Income	5.2M	13.9M	21.3M	20.5M	5.3M	11.2M	13.8M	6.9M	0.00	--	495,900	108,000	668,900
Fair Value Change Income	4.1M	-1,800	42,700	143,500	--	--	--	--	--	--	--	--	--
Asset Disposal Income	-248,900	7.1M	4.3M	2.3M	5.1M	824,900	181,500	26,200	-19,900	--	--	--	--
Asset Impairment Loss	37.7M	10.0M	359.0M	315,500	339,700	406,500	4.9M	3.4M	2.1M	1.6M	1.6M	1.7M	1.0M
Other Income	6.1M	14.9M	9.1M	8.7M	6.6M	6.3M	5.0M	5.7M	--	--	--	--	--
Income Before Tax	-833.0M	36.8M	2.1B	1.1B	464.0M	155.0M	126.0M	109.0M	84.9M	74.2M	72.8M	33.1M	22.4M
Income Tax	117.0M	-31.7M	326.0M	172.0M	69.3M	17.6M	19.2M	17.7M	10.3M	9.7M	9.3M	4.0M	2.6M
+Net Income	-950.0M	68.5M	1.8B	885.0M	395.0M	137.0M	107.0M	91.8M	74.6M	64.4M	63.5M	29.2M	19.7M
Net Margin %	-116.4%	6.2%	32.2%	33.1%	29.2%	18.8%	18.4%	19.2%	18.7%	18.7%	24.0%	15.9%	14.2%
Net Income Attributable	-655.0M	140.0M	1.7B	852.0M	363.0M	147.0M	114.0M	93.2M	76.1M	65.2M	63.5M	29.2M	19.7M
Minority Interest	-295.0M	-72.0M	75.8M	32.8M	32.0M	-10.3M	-7.3M	-1.4M	-1.5M	-796,000	--	--	-800.00
Eps Basic	-1.02	0.25	2.62	1.94	1.33	0.70	0.53	0.57	1.13	0.97	1.02	0.49	0.31
Eps Diluted	-1.02	0.25	2.62	1.94	1.33	0.70	0.53	0.57	1.13	0.97	1.02	0.49	0.31

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012
Cash And Equivalents	712.0M	765.0M	1.0B	522.0M	391.0M	257.0M	62.8M	186.0M	51.4M	47.3M	108.0M	102.0M	23.6M
Trading Financial Assets	627,800	307.0M	387.0M	677.0M	860.0M	5.0M	--	--	--	--	--	--	--
Accounts Receivable	1.1B	1.9B	2.7B	1.1B	573.0M	333.0M	262.0M	200.0M	147.0M	120.0M	90.3M	62.4M	44.9M
Notes Receivable	4.3M	2.5M	3.9M	6.9M	3.6M	5.0M	3.8M	4.9M	3.5M	619,900	131,400	542,500	230,400
Notes And Accounts Receivable	1.1B	1.9B	2.7B	1.1B	577.0M	338.0M	266.0M	205.0M	151.0M	121.0M	90.4M	62.9M	45.1M
Prepayments	5.3M	11.4M	19.3M	9.8M	7.2M	4.1M	5.1M	3.3M	2.4M	2.3M	1.3M	741,300	4.3M
Inventory	65.7M	99.6M	119.0M	147.0M	96.3M	43.4M	40.2M	32.5M	34.8M	29.3M	23.6M	14.9M	14.7M
Total Current Assets	2.2B	3.2B	4.4B	2.6B	2.0B	665.0M	709.0M	697.0M	249.0M	206.0M	230.0M	186.0M	105.0M
Long Term Equity Investment	36.0M	30.4M	30.8M	32.0M	--	--	--	--	--	--	--	--	--
Fixed Assets	--	1.2B	1.2B	1.1B	549.0M	360.0M	321.0M	262.0M	250.0M	139.0M	43.2M	27.9M	19.9M
Fixed Assets Total	1.2B	1.2B	1.2B	1.1B	549.0M	360.0M	321.0M	262.0M	250.0M	139.0M	43.2M	27.9M	19.9M
Construction In Progress	--	171.0M	58.6M	38.3M	49.7M	52.9M	26.2M	17.1M	19.8M	91.7M	56.9M	13.7M	842,200
Construction In Progress Total	233.0M	171.0M	58.6M	38.3M	49.7M	52.9M	26.2M	17.1M	19.8M	91.7M	56.9M	13.7M	842,200
Intangible Assets	259.0M	250.0M	185.0M	100.0M	101.0M	95.2M	24.7M	27.0M	31.2M	35.0M	30.9M	34.3M	37.7M
Long Term Deferred Expenses	37.0M	52.7M	48.1M	58.0M	32.6M	32.1M	26.2M	16.3M	12.3M	6.8M	5.7M	2.1M	1.4M
Total Non Current Assets	2.4B	2.5B	2.3B	1.7B	895.0M	632.0M	479.0M	372.0M	330.0M	288.0M	155.0M	85.0M	64.7M
Total Assets	4.6B	5.7B	6.7B	4.2B	2.9B	1.3B	1.2B	1.1B	579.0M	494.0M	386.0M	271.0M	169.0M
Short Term Borrowings	21.6M	2.1M	98.5M	151.0M	75.3M	--	--	--	10.0M	--	--	26.5M	--
Accounts Payable	107.0M	144.0M	467.0M	221.0M	86.2M	35.9M	25.8M	17.3M	16.4M	31.5M	11.1M	11.1M	12.2M
Advance Receipts	--	--	--	--	--	4.4M	3.3M	1.1M	3.1M	2.8M	4.1M	4.5M	9.4M
Contract Liabilities	14.9M	8.9M	22.2M	13.2M	24.7M	--	--	--	--	--	--	--	--
Total Current Liabilities	442.0M	508.0M	1.4B	678.0M	303.0M	106.0M	96.4M	84.5M	60.6M	60.3M	39.7M	67.9M	36.6M
Long Term Borrowings	52.8M	28.3M	--	--	--	--	--	--	--	--	--	10.0M	--
Total Non Current Liabilities	135.0M	119.0M	151.0M	78.8M	19.7M	6.1M	11.7M	14.2M	16.9M	19.8M	1.4M	11.7M	2.3M
Total Liabilities	576.0M	627.0M	1.5B	756.0M	323.0M	112.0M	108.0M	98.7M	77.5M	80.1M	41.1M	79.6M	39.0M
Paid In Capital	647.0M	649.0M	440.0M	294.0M	235.0M	217.0M	182.0M	91.0M	67.5M	67.5M	67.5M	62.1M	59.0M
Capital Reserve	785.0M	878.0M	1.2B	1.3B	1.4B	424.0M	455.0M	534.0M	154.0M	154.0M	153.0M	69.1M	39.8M
Surplus Reserve	87.6M	87.6M	56.7M	52.3M	43.3M	35.4M	33.9M	16.0M	5.2M	4.7M	3.9M	2.2M	855,700
Retained Earnings	2.5B	3.2B	3.2B	1.6B	808.0M	496.0M	394.0M	343.0M	261.0M	185.0M	121.0M	59.3M	31.5M
Minority Equity	-62.9M	237.0M	320.0M	281.0M	144.0M	103.0M	113.0M	10.3M	12.2M	1.7M	--	--	--
Equity Attributable	4.1B	4.9B	4.9B	3.2B	2.4B	1.1B	967.0M	961.0M	489.0M	412.0M	345.0M	191.0M	130.0M
Total Equity	4.0B	5.1B	5.2B	3.5B	2.5B	1.2B	1.1B	971.0M	502.0M	414.0M	345.0M	191.0M	130.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012
Cash From Sales	1.0B	2.0B	3.9B	2.2B	1.2B	687.0M	547.0M	445.0M	390.0M	336.0M	257.0M	175.0M	140.0M
Tax Refunds Received	12.7M	57,200	908,100	629,800	633,700	--	--	9,000	--	--	--	--	--
Total Operating Cash Inflow	1.1B	2.1B	3.9B	2.2B	1.2B	700.0M	558.0M	452.0M	397.0M	343.0M	259.0M	184.0M	144.0M
Cash Paid For Goods	171.0M	490.0M	1.1B	739.0M	281.0M	92.6M	62.9M	51.5M	50.6M	50.7M	46.4M	42.2M	43.2M
Cash Paid To Employees	380.0M	512.0M	647.0M	319.0M	181.0M	156.0M	121.0M	97.2M	76.6M	67.7M	48.9M	35.2M	27.2M
Taxes Paid	130.0M	365.0M	312.0M	172.0M	95.3M	54.5M	50.1M	42.1M	44.9M	33.9M	29.2M	17.9M	9.3M
Total Operating Cash Outflow	997.0M	1.8B	2.6B	1.6B	883.0M	587.0M	478.0M	373.0M	334.0M	294.0M	224.0M	161.0M	128.0M
Operating Cash Flow	78.8M	320.0M	1.3B	631.0M	311.0M	113.0M	80.4M	79.3M	63.6M	48.5M	34.7M	22.9M	16.1M
Total Investing Cash Inflow	695.0M	1.1B	2.7B	2.8B	1.3B	733.0M	1.1B	612.0M	45.00	72,600	998,500	12.1M	73.7M
Total Investing Cash Outflow	805.0M	1.4B	3.3B	3.3B	2.4B	602.0M	1.3B	946.0M	77.3M	130.0M	79.7M	26.7M	95.1M
Investing Cash Flow	-110.0M	-285.0M	-605.0M	-503.0M	-1.2B	132.0M	-200.0M	-334.0M	-77.3M	-130.0M	-78.7M	-14.6M	-21.5M
Cash From Borrowings	55.3M	79.9M	201.0M	248.0M	81.3M	--	--	--	10.0M	--	--	39.9M	15.8M
Dividends And Interest Paid	44.5M	160.0M	114.0M	76.1M	43.8M	44.3M	45.5M	19,300	420,500	--	1.0M	1.3M	136,900
Debt Repayments	11.6M	148.0M	254.0M	172.0M	6.0M	--	--	10.0M	--	--	39.7M	--	20.8M
Total Financing Cash Inflow	55.3M	79.9M	211.0M	319.0M	1.1B	1.0M	119.0M	404.0M	22.0M	20.2M	92.9M	72.3M	16.4M
Total Financing Cash Outflow	131.0M	374.0M	430.0M	310.0M	103.0M	44.7M	126.0M	16.0M	2.0M	1.9M	40.8M	4.3M	21.1M
Financing Cash Flow	-75.3M	-294.0M	-219.0M	8.5M	1.0B	-43.7M	-7.0M	388.0M	20.0M	18.3M	52.1M	68.0M	-4.7M
Net Change In Cash	-99.3M	-259.0M	498.0M	131.0M	134.0M	202.0M	-129.0M	133.0M	6.6M	-62.8M	8.0M	75.9M	-9.8M
Ending Cash Balance	662.0M	761.0M	1.0B	522.0M	391.0M	257.0M	55.6M	184.0M	51.4M	44.8M	108.0M	99.5M	23.6M
Capex	148.0M	385.0M	734.0M	641.0M	287.0M	197.0M	144.0M	67.0M	77.3M	130.0M	79.7M	26.7M	29.7M